Humana Inc. (NYSE:HUM) Shares Bought by OVERSEA CHINESE BANKING Corp Ltd

OVERSEA CHINESE BANKING Corp Ltd grew its holdings in Humana Inc. (NYSE:HUM) by 202.5% during the 3rd quarter, Holdings Channel reports. The firm owned 2,081 shares of the insurance provider’s stock after buying an additional 1,393 shares during the period. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Humana were worth $656,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. Sei Investments Co. increased its position in Humana by 0.4% during the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock worth $21,462,000 after buying an additional 264 shares in the last quarter. Avantax Advisory Services Inc. increased its position in Humana by 11.2% during the 1st quarter. Avantax Advisory Services Inc. now owns 2,721 shares of the insurance provider’s stock worth $943,000 after purchasing an additional 275 shares in the last quarter. ProShare Advisors LLC raised its stake in Humana by 3.4% in the 1st quarter. ProShare Advisors LLC now owns 19,962 shares of the insurance provider’s stock valued at $6,921,000 after purchasing an additional 658 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in shares of Humana by 356.0% during the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 87,939 shares of the insurance provider’s stock worth $30,490,000 after purchasing an additional 68,655 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of Humana by 17.5% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 143,684 shares of the insurance provider’s stock worth $49,818,000 after purchasing an additional 21,402 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of analyst reports. Leerink Partners lowered shares of Humana from an “outperform” rating to a “market perform” rating and decreased their target price for the stock from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Jefferies Financial Group cut Humana from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $519.00 to $253.00 in a report on Monday, October 7th. Royal Bank of Canada dropped their target price on Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Stephens reissued an “equal weight” rating and issued a $250.00 price target on shares of Humana in a research note on Wednesday, October 9th. Finally, Wells Fargo & Company dropped their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $315.86.

Humana Price Performance

Shares of HUM stock opened at $289.85 on Thursday. The firm has a fifty day simple moving average of $286.27 and a 200-day simple moving average of $332.44. The company has a market capitalization of $34.90 billion, a PE ratio of 25.64, a price-to-earnings-growth ratio of 2.21 and a beta of 0.52. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $527.18. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities research analysts anticipate that Humana Inc. will post 15.83 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.22%. Humana’s dividend payout ratio is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.